Status:
COMPLETED
Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting
Lead Sponsor:
Assiut University
Conditions:
Postoperative Nausea
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and...
Detailed Description
One of the gold standards for analgesia following cesarean delivery is intrathecal morphine, which is not devoid of complications namely postoperative nausea and vomiting. We evaluated the antiemetic ...
Eligibility Criteria
Inclusion
- females
- 18-40 years of age
- elective cesarean delivery under bupivacaine spinal anesthesia
Exclusion
- renal disease
- preeclampsia
- liver disease
- cardiac disease
- Coagulopathy
- chronic cough
- nausea
- vomiting
- patient refusal
Key Trial Info
Start Date :
March 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2017
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03387956
Start Date
March 20 2017
End Date
August 10 2017
Last Update
June 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emad Zarief Kamel Said
Asyut, Egypt, 71111